Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6496568

O=C(O)C(F)(F)F.O=C(O)CCCCNc1ncccn1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
HPGD P15428 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
APAF1 O14727 2/20 0.43
CASP6 P55212 2/20 0.43
CASP8 Q14790 2/20 0.43
RAD52 P43351 1/20 0.43
CASP7 P55210 1/20 0.43
HRH4 Q9H3N8 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
ITGB3 P05106 1/20 0.41
ITGAV P06756 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CDC25A P30304 1/20 0.38
CDC25B P30305 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PABPC1 P11940 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6670720 0.91 ALDH1A1 (0.54) ALDH1A1HPGDL3MBTL1ITGB3ITGAV
SCHEMBL5848939 0.85 ALDH1A1 (0.56) ALDH1A1HPGDITGB3ITGAVCDC25A
SCHEMBL6496575 0.78 ALDH1A1 (0.41) ALDH1A1HPGDL3MBTL1APAF1CASP6
SCHEMBL17234481 0.78 ALDH1A1 (0.60) ALDH1A1HPGDL3MBTL1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL3285581 0.74 ADORA1 (0.56) ALDH1A1CDC25ACDC25BRXFP1
Trifluoroacetic Acid SCHEMBL3285583 0.74 ADORA1 (0.56) ALDH1A1CDC25ACDC25BRXFP1
Trifluoroacetic Acid SCHEMBL3285320 0.74 ADORA1 (0.56) ALDH1A1CDC25ACDC25BRXFP1
SCHEMBL10767538 0.74 MAPK1 (0.49) ALDH1A1L3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL3148784 0.73 KMT2A (0.52) ALDH1A1L3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL18794901 0.72 ALDH1A1 (0.52) ALDH1A1HPGDITGB3ITGAVCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009843-A1 Medicine for inhibiting drug elimination pump TRINE PHARMACEUTICALS, INC. 2005-01-13 US disclosed
EP-1389463-A1 MEDICINE FOR INHIBITING DRUG ELIMINATION PUMP DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009843-A1 Medicine for inhibiting drug elimination pump ABCB11, ATP6AP1, HRH2 ALDH1A1 1997/4885HPGD 735/4885L3MBTL1 971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.